Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-03

Clinical Trial Update: Safety and Efficacy Study of Pilocarpine HCl Ophthalmic Solution in Participants With Presbyopia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating pilocarpine HCl ophthalmic solution for presbyopia, with the study currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pilocarpine HCl Ophthalmic Solution (pilocarpine hydrochloride ophthalmic solution)

Snippet

Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd. | Conditions: Presbyopia | Phase 3 | Status: NOT_YET_RECRUITING